Literature DB >> 24802959

Influence of infliximab pretreatment on ischemia/reperfusion injury in rat intestine.

Remzi Adnan Akdogan, Yıldıray Kalkan, Levent Tumkaya, Hasan Alacam, Başar Erdivanli1, İbrahim Aydin.   

Abstract

The Pringle maneuver is used in hepatic surgery to prevent blood loss but is associated with ischemia- reperfusion injury. To investigate the effect of infliximab on inflammation and apoptosis in rat intestinal mucosa during ischemia-reperfusion (IR) injury. A total of 30 male Wistar albino rats were equally divided into three groups to be subjected to (i) sham operation (sham), (ii) IR injury via Pringle maneuver (pringle) or (iii) infliximab (IFX) group (IFX was given at a dose 3 mg/kg for 3 days before IR injury). Following reperfusion period of 60 min., intestinal tissue and blood samples were taken and processed by standard histological methods. The Pringle maneuver and following reperfusion caused significant histopathological changes, increased serum transaminases' activity and the levels of oxidative stress markers and decreased glutathione peroxidase activity. IFX pretreatment partially prevented these changes. Infliximab pretreatment may protect intestinal mucosa against ischemia-reperfusion injury. Further studies are needed to investigate mechanism and evaluate safety and optimal dosing of IFX in humans exposed to the possible tissue damage by ischemia-reperfusion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24802959     DOI: 10.5603/FHC.2014.0004

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  3 in total

1.  Preconditioning with the BKCa channel activator NS-1619 prevents ischemia-reperfusion-induced inflammation and mucosal barrier dysfunction: roles for ROS and heme oxygenase-1.

Authors:  Hongyan Dai; Meifang Wang; Parag N Patel; Theodore Kalogeris; Yajun Liu; William Durante; Ronald J Korthuis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-19       Impact factor: 4.733

2.  Ischemic Preconditioning-Induced SOCS-1 Protects Rat Intestinal Ischemia Reperfusion Injury via Degradation of TRAF6.

Authors:  Sheng-Zhi Liu; Xue-Mei He; Xu Zhang; Fan-Cai Zeng; Fang Wang; Xiang-Yu Zhou
Journal:  Dig Dis Sci       Date:  2016-08-18       Impact factor: 3.199

Review 3.  Infliximab Can Improve Traumatic Brain Injury by Suppressing the Tumor Necrosis Factor Alpha Pathway.

Authors:  Yiru Zhou; Ruihua Fan; Benson O A Botchway; Yong Zhang; Xuehong Liu
Journal:  Mol Neurobiol       Date:  2021-01-27       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.